Evidence map›Paper›PMID 31396314›Full record

ArticleAmerican journal of translational research2019

Systematic understanding of the mechanism and effects of Arctigenin attenuates inflammation in dextran sulfate sodium-induced acute colitis through suppression of NLRP3 inflammasome by SIRT1.

Zhichen Pu, Chengzheng Han, Weiwei Zhang, Maodi Xu, Zijing Wu, Yanhao Liu, Min Wu, Hui Sun, Haitang Xie

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Zhichen PuAnhui Provincial Center for Drug Clinical Evaluation, Yijishan Hospital of Wannan Medical College Wuhu 241001, Anhui, China.
Chengzheng HanClinic of Integrated Traditional Chinese and Western Medicine, Yijishan Hospital of Wannan Medical College Wuhu 241001, Anhui, China.
Weiwei ZhangDepartment of Pharmacy, Fourth People's Hospital of Maanshan Maanshan 243031, Anhui, China.
Maodi XuAnhui Provincial Center for Drug Clinical Evaluation, Yijishan Hospital of Wannan Medical College Wuhu 241001, Anhui, China.
Zijing WuAnhui Provincial Center for Drug Clinical Evaluation, Yijishan Hospital of Wannan Medical College Wuhu 241001, Anhui, China.
Yanhao LiuAnhui Provincial Center for Drug Clinical Evaluation, Yijishan Hospital of Wannan Medical College Wuhu 241001, Anhui, China.
Min WuDepartment of Drug Consumption Supply, Wuhu Second People's Hospital Wuhu 241001, Anhui, China.
Hui SunState Key Laboratory of Natural Medicines, Key Lab of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University Tongjiaxiang 24, Nanjing 210009, China.
Haitang XieAnhui Provincial Center for Drug Clinical Evaluation, Yijishan Hospital of Wannan Medical College Wuhu 241001, Anhui, China.
First Affiliated Hospital of Wannan Medical College · CNWannan Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Arctigenin (ARC-G) is the main active ingredient extracted from Great Burdock Achene, with extensive pharmacological effects. In addition, ARC-G has been suggested to show excellent efficacy on inflammatory disease. This study aimed to defined that the function of Arctigenin attenuates inflammation in dextran sulfate sodium (DSS)-induced acute colitis, to determine its possible mechanism. Mice was induced by giving 2.0% DSS in the drinking water for DSS-induced acute colitis. Mice of acute colitis were injected intraperitoneally with 20 mg/kg per day of Arctigenin for 7 days. MPO activity levels were measured using MPO activity kits. Western Blot Analysis was used to determine the protein expression. Arctigenin prevents colitis and attenuates inflammation in DSS-induced acute colitis. Arctigenin suppressed NLRP3 inflammasome by SIRT1 in DSS-induced acute colitis. In THP-1 cell by LPS model, Arctigenin suppressed NLRP3, caspase-1 and IL-1β protein expression by SIRT1. Si-NLRP3 increases the effects of Arctigenin on inflammation in THP-1 cell by LPS model. Si-SIRT1 decreases the effects of Arctigenin on inflammation in THP-1 cell by LPS model. INF39, NLRP3 inhibitor also increased the effects of Arctigenin on inflammation in DSS-induced acute colitis. SIRT1 inhibitor also decreases the effects of Arctigenin on inflammation in DSS-induced acute colitis. Taken together our results demonstrated that Arctigenin attenuates inflammation in DSS-induced acute colitis through suppression of NLRP3 inflammasome by SIRT1.

Indexed as

acute colitisArctigeninNLRP3SIRT1

Identifiers

PMID31396314
PMCPMC6684881
OpenAlexW2981765497

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.